Applied DNA Sciences Inc (APDN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Applied DNA Sciences Inc (APDN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7964
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Applied DNA Sciences Inc (APDN) is a biotechnology company that provides DNA based security and authentication solutions and services. The company’s products comprise DNA security tools, DNA marking kit for assets and valuables, test kits, intruder and offender tagging systems; custom DNA sequences, and identity markers, among others. Its supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, and mark, track, and convict criminals; and fiberTyping, a test of native cotton fiber DNA. The company serves government and military, security and asset marking, industrial parts, pharmaceuticals, cannabis, textiles and apparel, personal care, fertilizer, and printing and packaging industries. APDN is headquartered in Stony Brook, New York, the US.

Applied DNA Sciences Inc (APDN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Applied DNA Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Applied DNA Sciences Acquires Assets of Vandalia Research 11
Partnerships 12
ACG World to Enter into Agreement with Applied DNA Sciences 12
Applied DNA Sciences Extends Contract with U.S. Defense Logistics Agency 13
Licensing Agreements 14
Colorcon Enters into Licensing Agreement with Applied DNA Sciences 14
Equity Offering 15
Applied DNA Sciences to Raise USD4.8 Million in Private Placement of Shares 15
Applied DNA Sciences Files Registration Statement to Raise USD11.3 Million in Public Offering of Shares upon Exercise of Warrants 16
Applied DNA Sciences Files Registration Statement to Raise USD5.4 Million in Private Placement of Shares upon Exercise of Warrants 17
Applied DNA Sciences to Raise USD1.8 Million in Private Placement of Shares 18
Applied DNA Sciences Raises USD5 Million in Private Placement of Shares and Warrants 19
Applied DNA Sciences Raises USD8.7 Million in Private Placement of Shares 20
Applied DNA Sciences Raises USD12 Million in Public Offering of Shares and Warrants 21
Applied DNA Sciences Raises USD9 Million in Public Offering of Shares and Warrants 23
Applied DNA Sciences Raises USD2.14 Million in Private Placement of Shares 25
Applied DNA Sciences Completes Private Placement Of Series B Preferred Stock For US$5.5 Million 26
Applied DNA Sciences Completes Private Placement Of Shares For US$2 Million 27
Applied DNA Sciences Completes Private Placement Of Series A Preferred Stock For US$5.5 Million 28
Applied DNA Sciences Completes Private Placement Of Shares For US$2 Million 29
Applied DNA Sciences Raises USD0.2 Million in Private Placement of Shares 30
Applied DNA Sciences Raises USD0.4 Million in Priavte Palcement of Shares 31
Applied DNA Sciences Completes Private Placement Of Common Stock For US$1.5 Million 32
Debt Offering 33
Applied DNA Sciences Raises USD1.7 Million in Private Placement of Notes 33
Applied DNA Sciences Inc – Key Competitors 34
Applied DNA Sciences Inc – Key Employees 35
Applied DNA Sciences Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 37
Strategy And Business Planning 37
Sep 18, 2018: Applied DNA forms wholly owned subsidiary, LineaRx, to develop large-scale, PCR-produced DNA for biotherapeutics 37
Financial Announcements 39
Aug 13, 2018: Applied DNA reports fiscal third quarter 2018 financial results 39
May 03, 2018: Applied DNA Reports Fiscal Second Quarter 2018 Financial Results 41
Feb 08, 2018: Applied DNA Reports Fiscal First Quarter 2018 Financial Results 43
Dec 28, 2017: Applied DNA Sciences Reports Year End and Fiscal Fourth Quarter Results 44
Dec 15, 2017: Applied DNA Announces Selected Preliminary Unaudited Fiscal Fourth Quarter and Year End Results 46
Dec 15, 2017: APDN Announces Selected Preliminary Unaudited Fiscal 4th Quarter and Year End Results 48
Aug 10, 2017: Applied DNA Reports Fiscal Third Quarter 2017 Financial Results 50
May 11, 2017: Applied DNA Sciences Reports Fiscal Second Quarter 2017 Financial Results 53
Feb 09, 2017: Applied DNA Sciences Reports Fiscal First Quarter 2017 Financial Results 55
Other Significant Developments 57
Oct 01, 2018: Linearx secures new RNA therapeutics customers for contract research services 57
Aug 02, 2018: Applied DNA Sciences reaches new milestones in therapeutic contract research and contract manufacturing of linear DNA 58
Oct 19, 2017: Applied DNA’s SigNature Molecular Tag Technology Inducted into Material ConneXion’s Innovation Library 59
Feb 14, 2017: APDN Builds Recurring Revenue in Synthetic Fiber Market with 3rd PO 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List of Tables
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Applied DNA Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 9
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Applied DNA Sciences Acquires Assets of Vandalia Research 11
ACG World to Enter into Agreement with Applied DNA Sciences 12
Applied DNA Sciences Extends Contract with U.S. Defense Logistics Agency 13
Colorcon Enters into Licensing Agreement with Applied DNA Sciences 14
Applied DNA Sciences to Raise USD4.8 Million in Private Placement of Shares 15
Applied DNA Sciences Files Registration Statement to Raise USD11.3 Million in Public Offering of Shares upon Exercise of Warrants 16
Applied DNA Sciences Files Registration Statement to Raise USD5.4 Million in Private Placement of Shares upon Exercise of Warrants 17
Applied DNA Sciences to Raise USD1.8 Million in Private Placement of Shares 18
Applied DNA Sciences Raises USD5 Million in Private Placement of Shares and Warrants 19
Applied DNA Sciences Raises USD8.7 Million in Private Placement of Shares 20
Applied DNA Sciences Raises USD12 Million in Public Offering of Shares and Warrants 21
Applied DNA Sciences Raises USD9 Million in Public Offering of Shares and Warrants 23
Applied DNA Sciences Raises USD2.14 Million in Private Placement of Shares 25
Applied DNA Sciences Completes Private Placement Of Series B Preferred Stock For US$5.5 Million 26
Applied DNA Sciences Completes Private Placement Of Shares For US$2 Million 27
Applied DNA Sciences Completes Private Placement Of Series A Preferred Stock For US$5.5 Million 28
Applied DNA Sciences Completes Private Placement Of Shares For US$2 Million 29
Applied DNA Sciences Raises USD0.2 Million in Private Placement of Shares 30
Applied DNA Sciences Raises USD0.4 Million in Priavte Palcement of Shares 31
Applied DNA Sciences Completes Private Placement Of Common Stock For US$1.5 Million 32
Applied DNA Sciences Raises USD1.7 Million in Private Placement of Notes 33
Applied DNA Sciences Inc, Key Competitors 34
Applied DNA Sciences Inc, Key Employees 35
Applied DNA Sciences Inc, Subsidiaries 36

List of Figures
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Applied DNA Sciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Applied DNA Sciences Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Applied DNA Sciences Inc (APDN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Itron Inc (ITRI):電力:M&Aディール及び事業提携情報
    Summary Itron Inc (Itron) is a technology and services company, which enables utilities and cities to provide critical infrastructure services. It offers solutions that help measure, manage and analyze energy and water use. The company’s solutions include metering systems, standard meters, next-gene …
  • John Keells Hotels Plc
    John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • SIRVA Inc:企業の戦略・SWOT・財務情報
    SIRVA Inc - Strategy, SWOT and Corporate Finance Report Summary SIRVA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Parker Drilling Co (PKD):企業の財務・戦略的SWOT分析
    Parker Drilling Co (PKD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Kowa Co Ltd (7807):企業の財務・戦略的SWOT分析
    Kowa Co Ltd (7807) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Compagnie Ivoirienne d’Electricite (CIEC):企業の財務・戦略的SWOT分析
    Summary Compagnie Ivoirienne d'Electricite (CIE), a subsidiary of Eranove, is a power company that provides power generation, transmission, and distribution services. The company offers exporting, importing and marketing of electricity. It provides operation and management of hydroelectric and therm …
  • TxCell SA (TXCL):企業の財務・戦略的SWOT分析
    Summary Txcell SA (Txcell) a subsidiary of Sangamo Therapeutics Inc, is a biotechnology company that develops personalized cellular immunotherapies using regulatory T cells (Treg) for the treatment of autoimmune and inflammatory diseases as well as transplantation-related inflammatory disorders. The …
  • VEON LTD. (VIP):企業の財務・戦略的SWOT分析
    VEON LTD. (VIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Merz Pharma GmbH & Co KgaA-医療機器分野:企業M&A・提携分析
    Summary Merz Pharma GmbH & Co KgaA (Merz Pharma) is an aesthetics and neurotoxin company that develops products for aesthetic and medical dermatology and neurological movement disorders. The company’s products include aesthetics, ethical drugs, over-the-counter drugs, neurology, and central nervous …
  • DiaSys Diagnostic Systems GmbH:医療機器:M&Aディール及び事業提携情報
    Summary DiaSys Diagnostic Systems GmbH (DiaSys Diagnostic) is a developer, manufacturer and marketer of point of care diagnostic products. The company’s products include automated analyzers, calibrators or controls, POCT systems and tests, reagents, system kits and OEM products. It provides automate …
  • Valora Holding AG (VALN):企業の財務・戦略的SWOT分析
    Valora Holding AG (VALN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Regulus Therapeutics Inc (RGLS):医療機器:M&Aディール及び事業提携情報
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • Qatar Electricity & Water Co QPSC (QEWS):企業の財務・戦略的SWOT分析
    Qatar Electricity & Water Co QPSC (QEWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Bioneer Corp (064550):企業の財務・戦略的SWOT分析
    Bioneer Corp (064550) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Arcbest Corp.
    Arcbest Corp. - Strategy, SWOT and Corporate Finance Report Summary Arcbest Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Donaldson Company, Inc.:企業の戦略・SWOT・財務分析
    Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Donaldson Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Atomenergoprom:企業の戦略的SWOT分析
    Atomenergoprom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • PhaseRx Inc (PZRX)-製薬・医療分野:企業M&A・提携分析
    Summary PhaseRx Inc (PhaseRx), formerly PhaseRx Pharmaceuticals Inc is a healthcare products provider that conducts research and develops RNA nanomedicines for the treatment of orphan diseases. The company discovers and develops drugs based on SMARTT polymer technology, which offers mRNA delivery te …
  • Canadian Natural Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Canadian Natural Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Canadian Natural Resources Ltd (Canadian Natural) is an independent upstream oil and gas company. The company carries out acquisition, exploration, development, production, marketing a …
  • Scatec Solar ASA (SSO):企業の財務・戦略的SWOT分析
    Scatec Solar ASA (SSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆